A Single and Multiple Ascending Dose Study of COR588

Clinical trial NCT04920903 · COMPLETED

Trial details

NCT number: NCT04920903
Sponsor: Cortexyme Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2021-08-26
Primary completion: 2022-04-30
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.